Search Results
37 Results Found for “social awareness”
The impact on patients diagnosed with tenosynovial giant cell tumour (TGCT) can be profound. It is characterized by high recurrence rates, chronic symptoms, and frequent delays in specialist care. Although it is a benign tumor, diffuse TGCT often requires complex multidisciplinary management similar to that used in sarcoma care. In this interview, Dr Sydney Stern (Head of TGCT Support Programs) discusses the evolving treatment landscape, the promise of targeted therapies, and the role of patient advocacy in improving outcomes for people living with this rare tumour.
We often focus on clinical excellence, but spend less time developing broader skills that could help us better lead with purpose and build more fulfilling, impactful careers. In this episode, part of a mini-series in partnership with LEADderm, Dr Jennifer Soung and Denise Mann explore how clinicians can engage with the media to educate, empower and extend their impact beyond the clinic.
Pancreatic cancer (PC) is the tenth most common cancer in 2024, with 66,440 new cases and 51,570 deaths.1,2 Globally, the prevalence varies from 10/100,000 cases in the Americas and Europe to 0.9/100,000 cases in South Central Asia and most of Africa.3 Currently, it has the ...
Have you ever considered what advocacy truly means? What it represents for you, your patients, and your colleagues? We’re confident that you already act as an advocate, but can you identify yourself as one? Let’s explore together! ...
Early-onset lung cancer is typically defined as occurring in individuals aged 18–50 years, although there is no universally accepted definition.1–3 This entity, though rare, poses unique diagnostic and therapeutic challenges. This article synthesizes current evidence on the unique features and management ...
Cancer nursing is central to delivering complex, evidence-based cancer care across Europe. To meet evolving needs, the EONS Education Working Group develops frameworks, training, networks, and safety initiatives. These efforts advance professional growth, strengthen education, and shape the future of cancer nursing—ultimately improving outcomes for patients and families.
In an evolving cancer landscape, cancer nurses are innovative leaders in cancer research. Their unique position at the intersection of clinical care and patient advocacy equips them to drive meaningful advancements in many critical areas, particularly symptom science.
This May, the World Bladder Cancer Patient Coalition (WBCPC) is launching Bladder Cancer Awareness Month 2025 under the theme “Feeling Unsure? Get Checked”. The campaign highlights the importance of recognising blood in urine as a symptom of bladder cancer and acting quickly to seek medical advice.
In this interview, Prof Mark Lawler discusses the Europe’s Beating Cancer Plan key achievements, challenges and future directions.
Cancer is a leading cause of death worldwide and represents a growing major public health problem. Every year on February 4, World Cancer Day serves as a global initiative to raise awareness, promote education, and drive action in the fight against ...
World Cancer Day is a campaign run by the Union for International Cancer Control (UICC). It is observed annually on February 4th, and unites the world in the fight against cancer. The theme for 2025–27, "United by Unique", highlights the individual ...
In this interview, we are joined by President-Elect of the European Cancer Organisation (ECO), Dr Isabel Teresa Rubio (Head of Breast Surgical Oncology at Clínica Universidad de Navarra, Professor of Surgery at the University of Navarra, Spain). She discusses ...
The incidence rate of breast cancer (BC) is the highest in Pakistan among all Asian countries.1 In 2018 alone, 2.1 million cases were diagnosed, although the exact number is likely much higher due to poor reporting in rural areas and the lack ...
touchONCOLOGY are delighted to support Global Liver Institute (GLI) as they officially launch their seventh annual #OctoberIs4Livers campaign, aiming to raise awareness about liver cancer and the disparities that affect communities at risk. This initiative comes in observance of Liver Cancer Awareness Month and this year focuses on the important theme “Addressing Disparities in Liver Cancer Care.”
The European Code of Cancer Practice The European Code of Cancer Practice is a patient-centred manifesto of the key features required to deliver good clinical cancer practice and improve patient outcomes in Europe.1,2 It builds upon the European Cancer Patient’...
Honouring the children and adolescents battling cancer September is Childhood Cancer Awareness Month: A time to recognise the children and adolescents affected by cancer at global and European scale. One would expect that it should be “children first” but sadly ...
The incidence and prevalence of most cancers is increasing worldwide because of the aging population, increased prevalence of established risk factors with urbanisation and economic development and changing social and demographic trends including late marriage and fewer child-births. Based on ...
It is well known that there is a demographic transition all over the world. The most important explanation to this is the change from previously large groups of children in a family to now commonly only one or two children ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
